Recent regulatory filings reveal that Valens Semiconductor Ltd. officer Yael Rozenberg has submitted a Form 144 proposing the disposal of 7,958 ordinary shares. This transaction highlights standard insider financial movements tracked closely by market observers and optical technology enthusiasts alike.
For more background on industry developments, you can check out our latest optics articles for comprehensive coverage. Understanding these administrative filings helps provide a clearer picture of corporate health across technology sectors.
Transaction Specifics and Broker Details
The estimated aggregate market value for the targeted stock transaction sits at approximately $12,653.22. Oppenheimer & Co. Inc. acts as the designated broker managing the execution on the New York Stock Exchange.
Execution Plan and Origin of Shares
The scheduled transaction takes place under a predetermined Rule 10b5-1 trading plan established earlier on March 17, 2026. These specific securities originate from previously vested restricted stock units acquired directly from the issuer.
- Total shares designated for the current sale: 7,958 ordinary shares.
- Acquisition timeframe of underlying RSUs: Between January 2024 and January 2026.
- Total company standing: Approximately 103 million ordinary shares outstanding.
Prior Disclosures and Market Standing
Historical filing data shows that Rozenberg previously sold a matching total of 7,958 shares across four separate transactions between July 20 and August 7, 2026. Netta Cohen signed the recent notice as an authorized signatory for Oppenheimer Israel.
Transparency and Corporate Position
The filing explicitly confirms that the reporting officer possesses no knowledge of undisclosed material adverse information regarding operations. Market participants often review such structured liquidity events alongside updates in optics news to gauge overall corporate stability.
Here is the source article for this story: Officer Yael Rozenberg proposes selling 7,958 shares of Valens Semiconductor (VLN).
